Multiple Assemblies exist for SMTL entry 1fbz
Structure-based design of a novel, osteoclast-selective, nonpeptide Src SH2 inhibitor with in vivo anti-resorptive activity; X-RAY DIFFRACTION 2.40 Å

	SMTL ID 1fbz.1 Ligands {4-[2-ACETYLAMINO-2-(3-CARBAMOYL-2-CYCLOHEXYLMETHOXY-6,7,8,9-TETRAHYDRO-5H-BENZOCYCLOHEPTEN-5YLCARBAMOYL)-ETHYL]-2-PHOSPHONO-PHENYL}-PHOSPHONIC ACID Polypeptides PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK Oligo-state monomer
	SMTL ID 1fbz.2 Ligands {4-[2-ACETYLAMINO-2-(3-CARBAMOYL-2-CYCLOHEXYLMETHOXY-6,7,8,9-TETRAHYDRO-5H-BENZOCYCLOHEPTEN-5YLCARBAMOYL)-ETHYL]-2-PHOSPHONO-PHENYL}-PHOSPHONIC ACID Polypeptides PROTO-ONCOGENE TYROSINE-PROTEIN KINASE LCK Oligo-state monomer